Programma

9:30 AM - 10:00 AM
Ontvangst en registratie
10:00 AM - 10:05 AM
Welkom
10:05 AM - 10:35 AM
Myositis, de nieuwe Nederlandse richtlijn myositis en highlights EULAR 2024
10:35 AM - 11:05 AM
CAR-T cel therapie voor auto-immuunziektes
11:05 AM - 11:20 AM
Oral abstract: POS1429 Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement
11:20 AM - 11:40 AM
Pauze
11:40 AM - 12:10 PM
Digitalisering van de reumazorg, Quo vadis?
12:10 PM - 12:40 PM
Uitkomstgerichte zorg
12:40 PM - 12:55 PM
Oral abstract: Effectiveness and cost-effectiveness of patient-initiated follow-up supported by asynchronous telemedicine in spondyloarthritis (TeleSpA-study): a pragmatic multicentre randomised controlled trial
12:55 PM - 1:40 PM
Lunchpauze
1:40 PM - 2:10 PM
Cardiovasculair risicomanagement in RMDs anno 2024
2:10 PM - 2:40 PM
Urinezuur: hoe belangrijk is het?
2:40 PM - 2:55 PM
Oral abstract: Support needs of gout patients and suitability of eHealth for (self-)management of gout
2:55 PM - 3:15 PM
Pauze
3:15 PM - 3:45 PM
Difficult to manage axiale spondyloarthritis en artritis psoriatica
3:45 PM - 4:15 PM
Update van de DMARD opties voor de behandeling van artritis psoriatica
4:15 PM - 4:30 PM
Oral abstract: POS0524 Exploring the interrelationships of Disease Activity, Illness Perceptions, Coping Strategies, Psychological Wellbeing, Central Sensitization and lifestyle factors in Axial Spondyloarthritis using Structural Equation Modeling
4:30 PM
Afsluiting en einde symposium